Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.21.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Income Statement [Abstract]    
Sales $ 275,039 $ 296,986
Cost of sales (159,466) (249,421)
Gross profit 115,573 47,565
Operating Expenses    
Selling and marketing 116,516 37,893
General and administrative 1,357,997 1,229,235
Depreciation and amortization 36,930 46,161
Total operating expenses 1,511,443 1,313,289
Loss from Operations (1,395,870) (1,265,724)
Other Expense (Income)    
Interest expense, net 5,979 30,233
Forgiveness of PPP Loan (242,486)
Gains from foreign currency translation (19,003) (465)
Total other (income) expense (255,510) 29,768
Net Loss (1,140,360) (1,295,492)
Net loss attributable to non-controlling interest 27,509 42,645
Series B preferred stock dividends (179,770)
Net Loss Attributable to Common Stockholders $ (1,112,851) $ (1,432,617)
Net Loss per Common Share $ (0.18) $ (0.35)
Weighted Average Number of Common Shares Outstanding:    
Basic and Diluted 6,343,134 4,062,747